BioSig Technologies Files 8-K/A Amendment
Ticker: STEX · Form: 8-K/A · Filed: Jul 21, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K/A |
| Filed Date | Jul 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
BioSig Tech filed an 8-K/A amendment for financial statements, check the details.
AI Summary
BioSig Technologies, Inc. filed an amendment (8-K/A) on July 21, 2025, to its previous filing. This amendment relates to financial statements and exhibits, with the earliest event reported dating back to May 27, 2025, and a period of report ending March 31, 2025. The company is incorporated in Delaware and its principal executive offices are located in Los Angeles, California.
Why It Matters
This filing is an amendment to a previous report, indicating updates or corrections to financial statements and exhibits, which could impact investor understanding of the company's financial position.
Risk Assessment
Risk Level: low — This is a routine amendment filing for financial statements and exhibits, not indicating any immediate operational or financial distress.
Key Numbers
- 20250721 — Filing Date (Date the amendment was filed with the SEC.)
- 20250331 — Period of Report End Date (The financial reporting period covered by the filing.)
- May 27, 2025 — Earliest Event Reported Date (The date of the earliest event that is the subject of the Form 8-K.)
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Los Angeles, California (location) — Principal Executive Offices
FAQ
What is the purpose of this 8-K/A filing?
This filing is an amendment (Amendment No. 1) to a previous Form 8-K, specifically related to Financial Statements and Exhibits.
When was this amendment filed?
The amendment was filed on July 21, 2025.
What period does the financial information in this filing pertain to?
The period of report ends on March 31, 2025.
Where are BioSig Technologies, Inc.'s principal executive offices located?
The principal executive offices are located at 12424 Wilshire Blvd, Suite 745, Los Angeles, California 90025.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on July 21, 2025 regarding BioSig Technologies, Inc. (STEX).